Skip to main content

Threatening letters received by Scientists

Threatening letters received by Scientists

Threatening letters received by Scientists

Introduction

A number of international scientists who were part of the World Health Organization's International Agency for Research on Cancer (IARC) team involved in the independent research about the potential cancer risks associated with Roundup claim they received what can be termed as 'threatening letters' from Monsanto, the manufacturer of Roundup. The scientists did not take well to the request, with many firing back at Monsanto, calling the company out on what they saw as veiled threats. This came after IARC classified 'glyphosate', the active ingredient in Roundup as a probable human carcinogen. According to our sources, the letters politely ordered them to turn over all of their files or preserve them for pending legal action in the U.S. court. However, the company did not send those letters to U.S. scientists who worked with the IARC. Roundup has been linked to causing non-Hodgkin lymphoma following exposure to Roundup by farmers, landscapers, and other individuals. The recently formed Roundup MDL No. 2741 is presided by U.S. District Judge Vince Chhabria and the first trial in the Roundup litigation is set for June 18, 2018, in the Superior Court for the County of San Francisco. Plaintiffs allege that they or their decedents developed non-Hodgkin's lymphoma after using Roundup over the course of several or more years. Monsanto continues to claim that the product is safe for individual consumers and encourages its use by homeowners.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!